EP2155141B1 - Montage destiné à être utilisé avec un dispositif médical - Google Patents

Montage destiné à être utilisé avec un dispositif médical Download PDF

Info

Publication number
EP2155141B1
EP2155141B1 EP07748574.6A EP07748574A EP2155141B1 EP 2155141 B1 EP2155141 B1 EP 2155141B1 EP 07748574 A EP07748574 A EP 07748574A EP 2155141 B1 EP2155141 B1 EP 2155141B1
Authority
EP
European Patent Office
Prior art keywords
medical device
arrangement
filter
needle member
tip
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP07748574.6A
Other languages
German (de)
English (en)
Other versions
EP2155141A1 (fr
EP2155141A4 (fr
Inventor
Anna ELLSTRÖM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Carmel Pharma AB
Original Assignee
Carmel Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Carmel Pharma AB filed Critical Carmel Pharma AB
Publication of EP2155141A1 publication Critical patent/EP2155141A1/fr
Publication of EP2155141A4 publication Critical patent/EP2155141A4/fr
Application granted granted Critical
Publication of EP2155141B1 publication Critical patent/EP2155141B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2096—Combination of a vial and a syringe for transferring or mixing their contents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2006—Piercing means
    • A61J1/201—Piercing means having one piercing end
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2048—Connecting means
    • A61J1/2055—Connecting means having gripping means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2068—Venting means
    • A61J1/2075—Venting means for external venting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/2079—Filtering means
    • A61J1/2082—Filtering means for gas filtration

Definitions

  • the invention relates to a medical device and an arrangement for use with the medical device.
  • the invention can be implemented in various medical equipments and be used for a number of purposes, but hereinafter the particular, but not in no way limiting for the invention, fields of application constituting an arrangement used together with a device for aseptic preparation of drugs will be described.
  • a known problem associated with the preparation of drug solutions is the fact that medical bottles or vials normally are made of a non-compressible material, such as glass or plastic. To enable the vial to be drained off, air has to flow into the vial so as to avoid negative pressure in the drug vial which negative pressure otherwise counteracts or prevents further transportation of liquid from the vial to another receptacle such as syringe.
  • any kind of needle for penetration is used.
  • hollow needles are used for penetration of a closing (which can be made of rubber for instance) covering an opening of a drug vial.
  • a closing which can be made of rubber for instance
  • Such injection needles or cannulae can be used for enabling gas or liquid transportation between a drug vial and another receptacle.
  • the expression "piercing member” or “needle” used hereinafter is meant to comprise also spikes and similar components for penetration of such a closing in order to create a channel for the transportation of gas or liquid.
  • a medical device comprising such a needle has drawbacks because the person handling the device can due to incautiousness be injured by the needle. Furthermore, the package enclosing the device can be damaged by the needle during transport and storage of the device. To solve this problem such medical devices can be provided with a needle shield covering the tip of the needle, which shield functions as a protection during storage and the initial handling of the device.
  • US 5,102,406 is directed to a clean air tube which provides a constantly renewable source of purified air for loading into a medicament syringe prior to use of the syringe for withdrawing liquid medicament from a multi-dose vial.
  • the tube is fitted with a clean-filtering membrane, through which ambient air is filtered upon being drawn into the tube.
  • the disclosure also describes the sequence of steps involved in loading the syringe with clean-filtered air.
  • WO 02/11794 relates to a method for aseptic preparation with an injection syringe.
  • the syringe comprises a container for injection agent and an immovable connection nozzle connected to the container.
  • the method entails charging the container with air. Air is forced to pass through an air filter arranged on the connection nozzle. This enables the syringe container to be charged with aseptic air in a simple and reliable fashion.
  • the disclosure also concerns devices for performing the method, viz. an injection syringe equipped with an air filter in the connection nozzle, a filter unit connectable to an injection syringe's connection nozzle and a system comprising an injection syringe and a separate filter unit.
  • FR 2 850 564 relates to a device and a procedure for the extemporaneous preparation of an individual quantity of sterile treatment fluid that may be compressible, in particular a treatment gas, said device comprising a rigid cartridge with an outlet valve, an administration syringe and a filtration-type connection/sterilisation device.
  • the cartridge simply contains an individual quantity of treatment fluid under pressure, and the cylinder of the syringe is adapted to contain this individual quantity of sterile treatment fluid.
  • US 6,073,759 discloses a unit dose, gas-filled syringe that is filled with gas and packaged in a gas barrier material prior to use to increase shelf-life, that is, to minimize gas leakage and dilution of the contents of the springe.
  • the syringe is filled with a selected gas and sealed inside a container made from a high gas barrier material.
  • the container is also filled with the selected gas.
  • the container material is selected to have a gas transmission rate sufficient to prevent the selected gas from diffusing out of the container into the atmosphere.
  • the volume of gas in the container is greater that atmospheric pressure to prevent atmospheric contaminants from entering the container and springe.
  • An object of the invention is to provide a medical device and an arrangement for use with the medical device, which arrangement can reduce the total number of requisite components and/or provide an additional function to a medical device.
  • the invention aims to provide such an arrangement suitable for use together with a medical device for providing cleaned gas in a rational and safe way during preparation of drugs.
  • the object is achieved by a medical device and an arrangement according to claim 1.
  • an arrangement which comprises a shield for a tip of a needle member of a medical device, wherein the arrangement comprises a filter, preferably a particulate air filter for filtering gas to be transferred out from or into the medical device via the needle member when the arrangement is interconnected with the medical device, and the filter is integrated with or constitutes at least a portion of the needle member tip shield, two important functions are provided in one single component.
  • the needle member tip is protected or shielded and gas can be cleaned by means of the filter.
  • the invention is based on the insight that by providing a needle member tip shield with a filter two functions can be achieved in one and the same component.
  • the needle member tip shield is mainly or entirely constituted by the filter.
  • a medical device 1' for providing cleaned gas, for example air, to a receptacle and thereby facilitating conveyance of a substance out of the receptacle is illustrated.
  • a substance can be various solutions and liquids constituting drugs, for example cytotoxic drugs or antibiotics, for use in the field of medicine.
  • the device comprises a connector 2' and a container 3' which may form an integrated unit 4'.
  • the connector 2' is provided with a first means 5' for connection to a receptacle 6' or in other words a first connector portion 5'. See also figure 3 illustrating the device connected to a medicine bottle or vial 6', and the exploded view in figure 4 .
  • the first connection means 5' can be designed for connection to a bottle, such as the neck of a vial.
  • the first connection means 5' is constituted by a ring-shaped portion 7' for enclosing the neck 8' of a vial 6'.
  • the ring-shaped portion 7' has slits 9' so as to form flanges 10' which protrude downwardly.
  • the flanges 10' can be provided with hooks 11' or barbs for gripping around the neck 8' of the vial 6'.
  • the connector 2' is suitably provided with a second means 12' for connection to a transfer member 13' (illustrated in figures 3 and 4 ), such as an injector device to be interconnected with the connector, for conveyance of a substance out of the receptacle 6', or in other words; the connector 2 is suitably provided with a second connector portion 12'.
  • the second connection means 12' can comprise a luer lock coupling or bayonet coupling (not shown) to enable an injection device to be connected.
  • Both the injector device and the connector are suitably provided with a membrane so as to create a double membrane coupling between the injector and the current device.
  • the connector 2' is preferably provided with a piercing member, such as a hollow needle 14' (as illustrated) for penetration of a closing (not illustrated) made of rubber for instance, which closing covers the opening of a receptacle 6, such as vial.
  • a piercing member such as a hollow needle 14' (as illustrated) for penetration of a closing (not illustrated) made of rubber for instance, which closing covers the opening of a receptacle 6, such as vial.
  • the expression “needle” is meant to comprise spikes and similar components for penetration of such a closing in order to create a channel for transportation of gas.
  • a channel between the container 3' and the receptacle 6' to which the connector 2' is connected is created.
  • gas contained in the container 3' can be transferred from the container to the receptacle 6', i.e. gas can flow from the container 3' to the receptacle 6'.
  • the connector 2' and the container 3' may form an integrated unit 4'.
  • different types of coupling means 16' known from prior art can be used as long as an airtight, or at least a substantially airtight connection can be obtained between the current components 2', 3'.
  • the container 3' has to be filled with gas before connection of the connector 2' to a receptacle 6'.
  • the volume of the container 3' is variable.
  • the container comprise s a first portion 17' made by a relatively rigid material which first portion is coupled to the connector 2', and a second portion 18' made by a relatively flexible material attached to the first portion 17'.
  • the second portion 18' can be extensible by manipulation of for example a handle 20' arranged at the end of the container 3'.
  • the volume of the container 3' can be increased and decreased, respectively.
  • the container 3' can be designed as a bellow which is compressible and extendable by affecting the container manually.
  • the container 3' is preferably provided with said handle 20' for regulating the volume of the container 3'.
  • the volume of the container is variable as illustrated, there may be other ways to fill the container and at the same time ensure that the gas passes a filter 21'.
  • the gas container could be constituted by a sealed vacuum-packed flexible bag whose seal can be broken to allow gas to flow into the bag.
  • the amount of gas, preferably air, provided by the pre-filled container should be adapted to the volume of the receptacle which is to be drained off.
  • the volume of the gas when being in the receptacle should preferably correspond to the volume of the receptacle so as to enable the receptacle to be completely drained off. This implies that the volume of the cleaned or sterilized gas in the pre-filled container is preferably approximately equal to or larger than the volume of the receptacle provided that the pressure of the gas is substantially the same in the receptacle as in the container.
  • the volume of the gas should be in the interval 1-100 cm 3 at atmospheric pressure.
  • cleaned gas is meant that the gas has been filtered by a filter, such as a particulate air filter to remove particles and/or viable micro-organisms to such an extent that the gas is classified to be aseptic and accepted by the relevant authority and/or any standards.
  • the degree of purity can be expressed in the largest particles allowed to pass the filter for a given flow rate of gas. In some cases no or very few particles having a size exceeding 5 ⁇ m are allowed to occur in the cleaned gas. However, the allowed particle size is determined by the requirements in the current application. Some drug treatments require that substantially all particles having a size exceeding 0.15 ⁇ m are removed from the gas by the particulate air filter. As an example, a filter with the mesh size 0.2 ⁇ m can be used to remove substantially all particles and micro organisms of that size.
  • the arrangement 30' and the medical device 1' are interconnected with each other.
  • the arrangement comprises a shield 22' for covering the tip 23' of a needle member 14' of the medical device 1'.
  • a filter 21' is integrated with or constitutes at least a portion of the needle member tip shield 22'.
  • the filter is arranged to filter the gas to be transferred into the medical device via the needle member 14'.
  • the filter 21' is preferably a particulate air filter, for cleaning gas, such as air to be transferred into the medical device via the needle member 14'.
  • the needle member shield 22' comprises a holder or a frame 24' for accommodating the filter 21', hereinafter called particulate air filter, which frame 24' is connectable to the medical device 1', i.e. to the connector 2'.
  • the main portion of the needle member shield 22' is suitably constituted by the particulate air filter 21' which is arranged for cleaning gas to be transported from the environment into the container 3'.
  • the particulate air filter 21' is arranged to clean gas which passes the particulate air filter 21' during filling the container 3' with gas (by increasing the volume of the container 3') before connection of the connector 2' to a receptacle 6'.
  • the filter is integrated with or constitutes at least a portion of the needle member tip shield.
  • the expressions "integrated with” and “constitutes at least a portion of” are intended to comprise an arrangement where the filter is releasably or permanently connected to the needle member tip shield or is made in one piece with the shield, as well as embodiments where the filter itself constitutes a portion of or the entirely needle member tip shield.
  • the arrangement could comprise two or more filters.
  • T he needle member tip shield is adapted to be arranged to at least partially cover or surround the tip of a needle member of a medical device when the arrangement is interconnected with the medical device.
  • the needle member tip shield covers the tip at least in one direction so as to avoid a user of the arrangement to be injured by the needle due to incautiousness.
  • the shield can be arranged immediately in front of the tip so as to cover the tip in the longitudinal direction of the needle member.
  • the shield can also be designed as a tube, or as a part or parts of a tube, which surrounds the needle tip. Such a shield rather covers the tip in a direction substantially perpendicular to the longitudinal direction of the needle member but extends beyond the tip in the longitudinal direction of the needle and away from the needle member so as to prevent contact with the needle member tip also in the longitudinal direction.
  • the particulate air filter 21' is preferably adapted to be arranged in front of the tip 23' of the needle member 14' and to at least partially cover or surround the tip of the needle member 14' of the medical device when the arrangement is interconnected with the medical device.
  • the particulate air filter 21' may be arranged in a frame or holder 24' or similar which in turn fits to the connector 2'.
  • the air particulate filter 21' itself can be designed to be engaged with the connector 2' and/or with the needle member 14', or the particulate air filter 21' can be partly penetrated by the needle member 14' so as to keep the particulate air filter 21' in position.
  • the particulate air filter 21' is adapted to be arranged to enclose the tip 23' of the needle member 14' of the medical device 1' when the arrangement 30' is interconnected with the medical device 1'.
  • the particulate air filter 21' can be provided with a channel 31' (illustrated in Fig. 1b ) for receiving the tip 23' of the needle member 14' therein.
  • the particulate air filter 21' preferably encloses the tip 23' of the needle member tightly so as to prevent gas transportation into or out from the needle member 14' without passing the particulate air filter 21'.
  • the particulate air filter 21' is designed and arranged as a protection portion of the needle member shield 22'. This implies that the particulate air filter 21' cleans the gas and at the same time the particulate air filter 21' functions as a protection during handling of the device 1', since the particulate air filter 21' at least partially covers or surround the tip 23' of the needle 14'. Furthermore, the needle member tip shield 22' protects the sterile package enclosing the device during transport and storage of the device.
  • the particulate air filter 21' is preferably arranged to abut against the needle member tip 23', or rather in immediate contact with the needle portion having an opening 32' for fluid transportation into or out from the needle member 14'. By covering the opening 32' of the needle 14' by means of the particulate air filter 21', it is ensured that the gas which is brought into the container 3' has to pass the particulate air filter 21'.
  • the arrangement and thus the needle member tip shield 22' is preferably adapted to be removably arranged on a medical device 1'. In the illustrated examples the needle member shield 22' is removed before connection of the medical device 1' to a vial 6' as further described hereinafter.
  • the arrangement 30' according to the invention and, thus the particulate air filter 21' is arranged to be removed from the integrated unit 4' after the container 3' has been filled with cleaned gas. Subsequently to filling the container 3' the particulate air filter 21' is removed and the connector 2' is to be connected to the receptacle 6'.
  • the particulate air filter 21' By removing the particulate air filter 21', after the container 3' has been filled with the gas and prior to interconnection of the connector 2' and the receptacle 6' to each other, any contamination particles removed from the gas and collected in the particulate air filter 21' are removed from the integrated unit 4'.
  • one and the same channel 15' can be used for both filling the container 3' with cleaned gas and transferring the cleaned gas from the container 3' to a receptacle 6'.
  • Fig. 5 a variant of the arrangement 30' according to the invention is illustrated.
  • the particulate air filter 21' is arranged in a frame 24' to be connected to a medical device and the particulate air filter 21' covers the needle member tip 23'.
  • the arrangement 30' can preferably be connected to the medical device, for example to the connector 2', so as to obtain a substantially airtight connection between the medical device and the needle member shield 22'.
  • a cover means for example a lid (not illustrated) can be arranged for covering the particulate air filter, preferably in an airtight manner.
  • the lid may have the function of preventing transportation of liquid, gas or any vapour in the direction from the medical device to the environment or in the opposite direction, i.e. into the medical device from the environment, so as to counteract that any undesired substance in the receptacle escapes to the environment or is introduced into the medical device, respectively.
  • Such a lid can be used to prevent further communication between the interior of the medical device and the environment via the particulate air filter after the container has been filled.
  • the container can be filled with the cleaned gas and thereafter the lid is mounted to cover the particulate air filter and prevent further gas transportation through the air particle filter. Thereafter, the arrangement can be removed from the medical device and the connector and the receptacle can be interconnected, and the subsequent manipulations can be safely executed.

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Claims (14)

  1. Dispositif médical (1') comportant un élément formant aiguille (14') et un agencement (30') destinés à être utilisés avec le dispositif médical (1') de manière à délivrer un gaz purifié à un réceptacle (6'), l'agencement (30') comprenant une protection (22') pour une pointe (23') d'un élément formant aiguille (14') d'un dispositif médical (1'), de telle sorte que l'agencement (30') comprend un filtre (21') destiné à filtrer un gaz à transférer à partir du dispositif médical (1') et dans celui-ci par l'intermédiaire de l'élément formant aiguille (14') lorsque l'agencement (30') est raccordé au dispositif médical, et en ce que le filtre (21') est intégré à la protection de la pointe de l'élément formant aiguille (22') ou constitue au moins une partie de celle-ci, de telle sorte que le filtre (21') est adapté afin d'être agencé de manière à recouvrir ou à entourer au moins partiellement la pointe (23') d'un élément formant aiguille d'un dispositif médical (1') lorsque l'agencement est raccordé au dispositif médical (1'), dans lequel le dispositif médical (1') comprend un raccord (2') et un conteneur (3') configuré de manière à être rempli avec un gaz qui passe à travers le filtre (21') avant que le dispositif médical (1') soit raccordé au réceptacle (6'), dans lequel le conteneur (3') présente un volume variable, caractérisé en ce que le conteneur (3') comprend une première partie (17') réalisée en un matériau relativement rigide, laquelle première partie est couplée au raccord (2'), et une seconde partie (18') réalisée en un matériau relativement flexible fixée sur la première partie (17'), de telle sorte que la restitution du volume dudit conteneur est variable.
  2. Dispositif médical (1') avec un agencement (30') selon la revendication 1, caractérisé en ce que le filtre (21') est adapté afin d'être agencé de manière à recouvrir une ouverture (32') d'un élément formant aiguille (14') du dispositif médical (1') lorsque l'agencement est raccordé au dispositif médical.
  3. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que le filtre (21') est adapté afin d'être agencé de manière à envelopper la pointe (23') de l'élément formant aiguille (14') du dispositif médical (1') lorsque l'agencement est raccordé au dispositif médical.
  4. Dispositif médical (1') avec un agencement (30') selon la revendication 3, caractérisé en ce que le filtre (21') est adapté de manière à être pénétré partiellement par la pointe (23') de l'élément formant aiguille (14').
  5. Dispositif médical (1') avec un agencement (30') selon la revendication 3, caractérisé en ce que le filtre (21') comporte un canal (31') destiné à recevoir la pointe (23') de l'élément formant aiguille (14').
  6. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que le filtre (21') est adapté afin d'être agencé face à la pointe (23') de l'élément formant aiguille (14') du dispositif médical (1') lorsque l'agencement est raccordé au dispositif médical.
  7. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que la protection de la pointe de l'élément formant aiguille (22') est constituée principalement ou totalement par le filtre (21').
  8. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que l'agencement (30') est adapté afin d'être agencé de manière amovible sur le dispositif médical (1').
  9. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que l'agencement (30) est adapté de manière à être raccordé au dispositif médical (1') afin d'obtenir une liaison sensiblement étanche à l'air entre le dispositif médical et l'agencement.
  10. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que le filtre (21') est un filtre à air particulaire.
  11. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que l'agencement (30') comprend un châssis (24') destiné à recevoir le filtre (21'), lequel châssis peut être raccordé au dispositif médical (1').
  12. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que l'agencement (30') est agencé de manière amovible sur le dispositif médical (1').
  13. Dispositif médical (1') avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que l'agencement (30') est agencé sur le dispositif médical (1') de manière à obtenir un raccordement sensiblement étanche entre le dispositif médical et l'agencement.
  14. Dispositif médical avec un agencement (30') selon l'une quelconque des revendications précédentes, caractérisé en ce que le dispositif médical (1') est un dispositif destiné à être utilisé pour la préparation de médicaments.
EP07748574.6A 2007-06-13 2007-06-13 Montage destiné à être utilisé avec un dispositif médical Active EP2155141B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SE2007/050414 WO2008153458A1 (fr) 2007-06-13 2007-06-13 Montage destiné à être utilisé avec un dispositif médical

Publications (3)

Publication Number Publication Date
EP2155141A1 EP2155141A1 (fr) 2010-02-24
EP2155141A4 EP2155141A4 (fr) 2013-12-25
EP2155141B1 true EP2155141B1 (fr) 2016-05-11

Family

ID=40129931

Family Applications (1)

Application Number Title Priority Date Filing Date
EP07748574.6A Active EP2155141B1 (fr) 2007-06-13 2007-06-13 Montage destiné à être utilisé avec un dispositif médical

Country Status (5)

Country Link
EP (1) EP2155141B1 (fr)
JP (1) JP5026590B2 (fr)
CA (1) CA2691276C (fr)
ES (1) ES2586679T3 (fr)
WO (1) WO2008153458A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013150579A1 (fr) 2012-04-02 2013-10-10 株式会社メディカルクリエーション Dispositif d'administration de médicament
JP5510986B2 (ja) 2012-04-02 2014-06-04 株式会社メディカルクリエーション 薬剤移送装置

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102406A (en) * 1989-06-02 1992-04-07 Arnold Victor A Device and method for avoiding contamination of multi-dose medicament vials
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
FR2850564A1 (fr) * 2003-02-05 2004-08-06 Arcadophta Dispositif et procede de preparation extemporanee d'une quantite individuelle de fluide sterile

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401432A (en) * 1982-05-26 1983-08-30 Boris Schwartz Storage, mixing and filtering receptacle for syringe
SE434700B (sv) * 1983-05-20 1984-08-13 Bengt Gustavsson Anordning for lufttet overforing av substans fran ett kerl till ett annat
DE3483475D1 (de) * 1983-05-20 1990-11-29 Bengt Gustavsson Anordnung zur uebertragung einer substanz.
EP0201611A1 (fr) * 1985-05-10 1986-11-20 B. Braun-SSC AG Seringue à deux canules
JPH06145B2 (ja) * 1986-02-15 1994-01-05 株式会社ニツシヨ− 無菌型溶解液導入器およびこれを用いた溶解液導入方法
GB2359754B (en) * 2000-03-03 2004-04-28 Nmt Group Plc Needle sheath
SE513225C2 (sv) 1998-12-03 2000-08-07 Carmel Pharma Ab Arrangemang, förfarande och gasbehållare för steril eller aseptisk hantering
SE517084C2 (sv) * 2000-08-10 2002-04-09 Carmel Pharma Ab Förfarande och anordningar vid aseptisk beredning
US6715520B2 (en) * 2001-10-11 2004-04-06 Carmel Pharma Ab Method and assembly for fluid transfer
US20050137523A1 (en) * 2003-12-22 2005-06-23 Wyatt Philip W. Medicament administration apparatus
GB0427507D0 (en) * 2004-12-16 2005-01-19 Frontier Plastics Ltd Improvements relating to injection syringes and needles
US7322941B2 (en) * 2005-09-13 2008-01-29 Modalworks Inc. Arterial syringe safety vent
WO2008036101A2 (fr) * 2005-11-07 2008-03-27 Industrie Borla S.P.A. Adaptateur de fiole aéré manipulable sans danger

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5102406A (en) * 1989-06-02 1992-04-07 Arnold Victor A Device and method for avoiding contamination of multi-dose medicament vials
US6073759A (en) * 1997-04-10 2000-06-13 Johns Hopkins University Pre-filled package containing unit dose of medical gas and method of making same
FR2850564A1 (fr) * 2003-02-05 2004-08-06 Arcadophta Dispositif et procede de preparation extemporanee d'une quantite individuelle de fluide sterile

Also Published As

Publication number Publication date
EP2155141A1 (fr) 2010-02-24
WO2008153458A1 (fr) 2008-12-18
CA2691276C (fr) 2014-09-16
JP2010528808A (ja) 2010-08-26
ES2586679T3 (es) 2016-10-18
JP5026590B2 (ja) 2012-09-12
EP2155141A4 (fr) 2013-12-25
CA2691276A1 (fr) 2008-12-18

Similar Documents

Publication Publication Date Title
US8622985B2 (en) Arrangement for use with a medical device
US8657803B2 (en) Device for providing fluid to a receptacle
EP2155143B1 (fr) Dispositif d'envoi de fluide dans un récipient
US11690788B2 (en) System for closed transfer of fluids
JP6355758B2 (ja) 流体の閉鎖移送のためのアダプタを有するシステム
US5289858A (en) System for accommodating withdrawal of liquid from a bulk supply
US20200130873A1 (en) Methods for preparing autologous blood eye drops
EP2155141B1 (fr) Montage destiné à être utilisé avec un dispositif médical
WO2020159558A1 (fr) Raccords pour permettre une mise en prise et un passage de fluide entre des récipients médicaux
KR20160061333A (ko) 어댑터를 의료 용기와 결합시키기 위한 조립체
WO2014210418A1 (fr) Ensemble raccord médical maintenant la stérilité et procédé
WO2019055197A1 (fr) Dispositifs et systèmes dotés d'un mécanisme de déplacement interne de contact sans contaminant de récipients et de dispositifs médicaux

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20091203

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: ELLSTROEM, ANNA

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20131121

RIC1 Information provided on ipc code assigned before grant

Ipc: A61J 1/20 20060101AFI20131115BHEP

17Q First examination report despatched

Effective date: 20140701

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20151202

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: AT

Ref legal event code: REF

Ref document number: 798047

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160515

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 10

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602007046270

Country of ref document: DE

REG Reference to a national code

Ref country code: SE

Ref legal event code: TRGR

REG Reference to a national code

Ref country code: LT

Ref legal event code: MG4D

REG Reference to a national code

Ref country code: NL

Ref legal event code: MP

Effective date: 20160511

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2586679

Country of ref document: ES

Kind code of ref document: T3

Effective date: 20161018

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: LT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

REG Reference to a national code

Ref country code: AT

Ref legal event code: MK05

Ref document number: 798047

Country of ref document: AT

Kind code of ref document: T

Effective date: 20160511

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160912

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160812

Ref country code: LV

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: DE

Ref legal event code: R097

Ref document number: 602007046270

Country of ref document: DE

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

26N No opposition filed

Effective date: 20170214

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160630

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160630

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 11

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO

Effective date: 20070613

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160613

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

Ref country code: MT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20160630

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20160511

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20230523

Year of fee payment: 17

Ref country code: FR

Payment date: 20230523

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20230523

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20230703

Year of fee payment: 17

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IE

Payment date: 20240523

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20240521

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20240521

Year of fee payment: 18